CTS is updating its guidance for full year 2024 sales to be in the range of $515 – $525 million compared to the prior range of $525 – $540 million and reiterating the adjusted diluted EPS guidance to be in the range of $2.05 – $2.25.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks